Although depression and anxiety are two distinct mental disorders, they often travel together. In fact, if you’ve been struggling with both depression and anxiety, you’re actually in the majority. Around 60 percent of people with depression also have an anxiety disorder, according to the Anxiety and Depression Association of America. These conditions often feed off each other, making it even harder to overcome them through traditional depression treatments.
That’s where ketamine therapy is changing the game.
At NeuPath Mind Wellness, we offer ketamine infusion therapy and Spravato (esketamine) treatment, two forms of ketamine-based care that have demonstrated fast and effective results for people living with both depression and anxiety.
In this post, we’ll take a look at depression and anxiety together, explain how ketamine works differently from conventional antidepressants, and why it can be successful at treating both conditions at once.
The Problem with Traditional Depression Treatments
Most traditional medications, like SSRIs and SNRIs, were designed primarily to treat depression. Some may help with anxiety as a secondary benefit, but the success rate is inconsistent and often unpredictable.
For people dealing with both conditions, this usually means going through a frustrating cycle of trying different medications, increasing doses, trying to mitigate side effects, and then waiting weeks or months to see if there is any improvement.
Research shows that more than one-third of people with depression don’t respond to standard antidepressants. When anxiety is also present, treatment becomes even more complicated.
That’s because these medications work by gradually altering serotonin or norepinephrine levels—a process that takes time (several weeks to months) and may have a limited impact on anxiety. Antidepressants are also notorious for causing side effects like weight gain, sexual dysfunction, or emotional blunting.
Why Ketamine Is Different
Ketamine works using a completely different mechanism than conventional antidepressants. Instead of altering serotonin or norepinephrine levels, it targets the glutamate system, a key neurotransmitter involved in mood regulation, learning, and memory. By acting on NMDA receptors, ketamine helps the brain form new neural connections—a process often impaired in both depression and anxiety.
This rapid rewiring effect is what gives ketamine its fast-acting antidepressant and anti-anxiety properties. Unlike traditional medications, which can take 6–8 weeks to show benefits, many patients feel relief within hours or days of their first ketamine infusion or Spravato treatment.
And here’s the key: ketamine doesn’t just mask symptoms. It helps break the feedback loops that keep depression and anxiety locked in place. This allows the body to actually adapt and overcome depression and anxiety. For people struggling with both conditions, ketamine therapy can be life-changing.
Treating Depression and Anxiety Together—Effectively
Given how often depression and anxiety occur together, and how poorly traditional treatment options address both conditions simultaneously, ketamine therapy should be a serious consideration as a first line treatment. Ketamine therapy is already building a compelling case in clinical research.
In clinical studies, ketamine has shown significant reductions in symptoms of generalized anxiety disorder (GAD), social anxiety, and panic disorder, even in patients who were also diagnosed with major depressive disorder (MDD). A study published in The American Journal of Psychiatry found that up to 70% of treatment-resistant patients experienced improvements in both depression and anxiety symptoms within 24 hours of a single dose of ketamine.
Spravato, the FDA-approved nasal spray form of esketamine, has also been shown to reduce symptoms of treatment-resistant depression when used alongside an oral antidepressant. Patients often report feeling more mentally clear, emotionally stable, and better able to function after just a few sessions.
Real Results, Real Relief
Here at NeuPath Mind Wellness in Delray Beach, we’ve seen firsthand how ketamine can make a difference where other treatments fall short. Patients often come to us after years of trying therapy, multiple medications, and even inpatient stays. They tell us they don’t have much hope since the other treatments didn’t work, but they’re willing to try anything to get rid of the depression and anxiety weighing them down.
Although skeptical, after just a few treatments that skepticism turns to hope. They describe feeling like “a fog has lifted” or that their minds are finally calm for the first time in years. They feel like themselves again. They sleep better. They feel less on edge. Their energy comes back. And their lives completely change for the better.
How to Start with Ketamine Therapy
We offer both IV ketamine infusions and Spravato treatments at our clinic in Delray Beach, Florida. To get started, simply schedule a new patient appointment. You will receive a thorough mental health evaluation by one of our providers. Based on the outcome of that evaluation, you may be recommended for ketamine infusion therapy, Spravato, or other treatment.
Your treatment plan will be unique to your needs and situation. A typical course of ketamine infusions or Spravato involves several sessions delivered over a couple of weeks. Both forms of ketamine therapy are well-tolerated by patients and effective for treatment of depression and anxiety.
Find Help Today
If you’ve been battling depression, anxiety, or both, it’s time to find a solution that works. Ketamine therapy is a fundamentally different approach that can bring fast, meaningful relief.
We’re here to help you find out if it’s the right treatment for you. Reach out to schedule a consultation at NeuPath Mind Wellness today. We are located in Delray Beach, Florida with close proximity to Palm Beach, Pompano Beach, Boca Raton, Fort Lauderdale and surrounding areas.
Call us today at 561-847-3662 or request an appointment online to get started.
Sources:
· Anxiety and Depression Association of America.
· The American Journal of Psychiatry, 2013.
· National Institute of Mental Health.
· Yale University School of Medicine – Ketamine Research.
